RADX vs GBIO
Comparison between Radiopharm Theranostics Ltd (RADX, Company) and Generation Bio Company (GBIO, Company).
Both RADX and GBIO are from the Healthcare sector.
RADX vs GBIO - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
RADX
$36M
GBIO
$36M
Max Drawdown
Winner
RADX
79.68%
GBIO
99.42%
Sharpe Ratio
Winner
RADX
0.45
GBIO
0.03
5Y Beta
RADX
0.44
GBIO
N/A
Industry
RADX
Biotechnology
GBIO
Biotechnology
P/E Ratio
RADX
N/A
GBIO
-0.57
Forward P/E
RADX
N/A
GBIO
7.87
Debt to Equity
RADX
N/A
GBIO
0.00%
P/S Ratio
RADX
2.22
GBIO
N/A
P/B Ratio
RADX
1.13
GBIO
N/A
RADX vs GBIO - Historical Returns
Returns include dividend reinvestment.
1M
RADX
-5.88%
Winner
GBIO
-2.55%
3M
RADX
-7.49%
Winner
GBIO
-2.38%
6M
RADX
-9.05%
Winner
GBIO
+30.24%
1Y
Winner
RADX
-9.83%
GBIO
-23.71%
5Y(CAGR)
RADX
N/A
GBIO
-56.15%
Max(CAGR)
RADX
-60.96%
Winner
GBIO
-49.19%
RADX vs GBIO - Annual Returns (2020 - 2026)
Returns include dividend reinvestment.
| Year | RADX | GBIO |
|---|---|---|
| 2026 | -16.28% | -1.93% |
| 2025 | +12.50% | -48.83% |
| 2024 | -74.59% | -43.01% |
| 2023 | N/A | -58.85% |
| 2022 | N/A | -49.36% |
| 2021 | N/A | -76.46% |
| 2020 | N/A | +14.82% |
RADX vs GBIO Drawdown Comparison
The maximum drawdown for RADX was -79.68%, occurring on Jul 7, 2025. This drawdown has not yet recovered.
The maximum drawdown for GBIO was -99.42%, occurring on Jun 27, 2025. This drawdown has not yet recovered.
The current RADX drawdown is -77.14%. The current GBIO drawdown is -98.97%.
| Rank | RADX | GBIO |
|---|---|---|
| #1 | -79.68% Dec 6, 2024 - Jul 7, 2025 | -99.42% Dec 2, 2020 - Jun 27, 2025 |
| #2 | N/A | -31.91% Sep 2, 2020 - Nov 13, 2020 |
| #3 | N/A | -26.81% Jun 12, 2020 - Aug 26, 2020 |
| #4 | N/A | -11.32% Nov 17, 2020 - Nov 24, 2020 |
Correlation
Correlation between RADX and GBIO is 0.07 which considered as a very weak or no correlation - the stocks move independently of each other.
0.07
-101
Select Stocks to Compare
Popular: RADX vs SPYGBIO vs SPY
More Comparisons
Compare with similar stocks